ACC.24 Congress Coverage: Empagliflozin after Acute Myocardial Infarction

ACC.24: Zilebesiran as Add-on Therapy in Patients with Hypertension Not Adequately Controlled by a Standard of Care...

ACC.24: IMPROVE-HCM trial...

ACC.24: RELIEVE-HF trial...

ACC.24: REDUCE-IT trial - Lipoprotein(a) Blood Levels and Cardiovascular Risk Reduction With Icosapent Ethyl...

ACC.24: VICTORION-INITIATE trial - An “Inclisiran First” Strategy vs Usual Care in Patients With Atherosclerotic Cardiovascular Disease...

ACC.24: BE ACTIVE Trial - Effect of Gamification, Financial Incentives, or Both to Increase Physical Activity Among Patients at High Risk of Cardiovascular Events...

ACC.24: TACTiC Trial...

Infarction ACC.24: AEGIS-II Trial...

ACC.24: ARISE-HF Trial...